These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22369874)

  • 1. Combining immunofluorescence and electron microscopy with quantum dots.
    Duyckaerts C; Lainé J
    Am J Pathol; 2012 Apr; 180(4):1356-7. PubMed ID: 22369874
    [No Abstract]   [Full Text] [Related]  

  • 2. Atomic identification of fluorescent Q-dots on tau-positive fibrils in 3D-reconstructed pick bodies.
    Uematsu M; Adachi E; Nakamura A; Tsuchiya K; Uchihara T
    Am J Pathol; 2012 Apr; 180(4):1394-7. PubMed ID: 22322305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pick body].
    Yoshida M
    Nihon Rinsho; 2011 Oct; 69 Suppl 8():171-5. PubMed ID: 22787775
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silver staining profiles distinguish Pick bodies from neurofibrillary tangles of Alzheimer type: comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 May; 109(5):483-9. PubMed ID: 15759128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A light scattering assay for arachidonic acid-induced tau fibrillization without interfering micellization.
    Sarthy J; Gamblin TC
    Anal Biochem; 2006 Jun; 353(1):150-2. PubMed ID: 16620751
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.
    Buée-Scherrer V; Buée L; Hof PR; Leveugle B; Gilles C; Loerzel AJ; Perl DP; Delacourte A
    Am J Pathol; 1995 Apr; 146(4):924-32. PubMed ID: 7717459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of paired helical filaments by scanning transmission electron microscopy.
    Ksiezak-Reding H; Wall JS
    Microsc Res Tech; 2005 Jul; 67(3-4):126-40. PubMed ID: 16104001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitration of tau protein is linked to neurodegeneration in tauopathies.
    Horiguchi T; Uryu K; Giasson BI; Ischiropoulos H; LightFoot R; Bellmann C; Richter-Landsberg C; Lee VM; Trojanowski JQ
    Am J Pathol; 2003 Sep; 163(3):1021-31. PubMed ID: 12937143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELISA-quantitation of phosphorylated tau protein in the Alzheimer's disease brain.
    Herrmann M; Golombowski S; Kräuchi K; Frey P; Mourton-Gilles C; Hulette C; Rosenberg C; Müller-Spahn F; Hock C
    Eur Neurol; 1999; 42(4):205-10. PubMed ID: 10567816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin labeling of neuronal fibrillar tau inclusions in human brain samples.
    Mohorko N; Repovs G; Popović M; Kovacs GG; Bresjanac M
    J Neuropathol Exp Neurol; 2010 Apr; 69(4):405-14. PubMed ID: 20448485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Golgi apparatus and the pathogenesis of Alzheimer's disease.
    Dal Canto MC
    Am J Pathol; 1996 Feb; 148(2):355-60. PubMed ID: 8579097
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
    Brion JP
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
    Gómez-Ramos P; Morán MA
    Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tau gene mutation].
    Iijima M
    No To Shinkei; 2002 Sep; 54(9):743-52. PubMed ID: 12428361
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neuropathology of tauopathy].
    Yoshida M
    Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal Sp1 transcription factor expression in Alzheimer disease and tauopathies.
    Santpere G; Nieto M; Puig B; Ferrer I
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):30-4. PubMed ID: 16378688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of transcription factors c-Fos, c-Jun, CREB-1 and ATF-2, and caspase-3 in relation with abnormal tau deposits in Pick's disease.
    Nieto-Bodelón M; Santpere G; Torrejón-Escribano B; Puig B; Ferrer I
    Acta Neuropathol; 2006 Apr; 111(4):341-50. PubMed ID: 16496165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.